Percutaneous coronary intervention with drug‐coated balloon‐only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30558
Abstract: At least 1 month of dual antiplatelet therapy is required after coronary stenting. The aim of this all‐comers retrospective registry study was to assess the efficacy and safety of percutaneous coronary intervention (PCI) using drug‐coated… read more here.
Keywords: percutaneous coronary; coated balloon; coronary intervention; drug coated ... See more keywords
Risk of colonoscopic post-polypectomy bleeding in patients on single antiplatelet therapy: systematic review with meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Surgical Endoscopy"
DOI: 10.1007/s00464-021-08975-0
Abstract: It was not yet fully established whether the use of antiplatelet agents (APAs) is associated with an increased risk of colorectal post-polypectomy bleeding (PPB). Temporarily, discontinuation of APAs could reduce the risk of PPB, but… read more here.
Keywords: risk; ppb; single antiplatelet; polypectomy ... See more keywords
Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.
Sign Up to like & getrecommendations! Published in 2018 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2018.07.083
Abstract: INTRODUCTION The potential benefit and risks of dual antiplatelet therapy (DAPT) over single antiplatelet therapy (SAPT) in patients who undergo coronary artery bypass graft surgery (CABG) is controversial. METHODS We performed a systematic review and… read more here.
Keywords: dapt; graft; antiplatelet therapy; single antiplatelet ... See more keywords
Abstract 4135791: Bleeding risk with non-vitamin K antagonist oral anticoagulants versus single antiplatelet therapy: A systematic review and meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4135791
Abstract: Background: While non-vitamin K antagonist oral anticoagulants (NOACs) are more effective than single antiplatelets (mostly low-dose aspirin) at reducing stroke risk in patients with atrial fibrillation (AF), differences in bleeding risk between NOACs and single-dose… read more here.
Keywords: single antiplatelet; risk; events trials; trials high ... See more keywords
Flow diverter stents with hydrophilic polymer coating for the treatment of acutely ruptured aneurysms using single antiplatelet therapy: Preliminary experience
Sign Up to like & getrecommendations! Published in 2020 at "Interventional Neuroradiology"
DOI: 10.1177/1591019920950878
Abstract: Background The use of flow diverter stent (FDS) has limitations in cases of subarachnoid haemorrhage caused by ruptured aneurysm, due to the need for double antiplatelet therapy and the delay in the aneurysm occluding. The… read more here.
Keywords: antiplatelet; antiplatelet therapy; ruptured aneurysms; flow diverter ... See more keywords
Initial Experience with the Derivo 2Heal Flow Diverter under Standard or Reduced-Dose Single Antiplatelet Therapy
Sign Up to like & getrecommendations! Published in 2024 at "American Journal of Neuroradiology"
DOI: 10.3174/ajnr.a8292
Abstract: BACKGROUND AND PURPOSE: Flow diverters with surface modifications or coatings have been recently introduced to clinical practice with the expectation that they can reduce the rate of thromboembolic complications and residual aneurysms. The purpose of… read more here.
Keywords: derivo 2heal; single antiplatelet; flow diverter; antiplatelet therapy ... See more keywords